Table 1.
Baseline characteristics.
| Baseline Variables | Median (Min–Max) or n (%) |
|---|---|
| Age (years) | 73 (49–85) |
| LED24h (mg) | 1337 (677–3033) |
| Number of levodopa doses, 06:00–22:00 | 7 (5–9) |
| Levodopa dose interval (h) | 2.5 (1.5–3) |
| Single dose effect duration (h) 1 | 2.0 (1.0–3.0) |
| OM ON-time, 06:00–22:00 1 | 12 (4–16) |
| BK (median score 09:00–18:00) | 22.8 (8.9–37.3.1) |
| DK (median score 09:00–18:00) | 4.6 (0.6–46.3) |
| FDS | 11.7 (4.5–25.8) |
| PTT (09:00–18:00), % | 0.8 (0.1–46.5) |
| OM OFF episodes absent, n (%) 1 | 14 (31.1) |
1 Determined by visual assessment of the PKG report by an experienced examiner (F.B.). Abbreviations: BK: bradykinesia score, DK: dyskinesia score, FDS: fluctuations dyskinesia score, PTT: percent time with tremor and OM: Objective Measure.